May 2nd - 4th, 2018

Paris, France

#GMTCC

2018 Programme - Paris

Sessions are tentative and subject to change. Last update: 06 February 2018.

Click here to view the programme in PDF.

2 May

10.45 - 13.00

MedTech Europe Ethics & Compliance Committee (ECC) Meeting (MEMBERS ONLY)
(Napoleon Room)

AdvaMed DDCG Meeting (Members ONLY)
(Concorde Ballroom)

SME Compliance Workshop (in French)  (confirmed)
(Aiglon Room)

13.00 - 14.00Lunch ECC-DDCG-SME Bootcamp
(Imperial Room)
14.00 - 15.45

MedTech Europe Ethics & Compliance Committee (ECC) Meeting (MEMBERS ONLY) - continuation
(Napoleon Room)

AdvaMed DDCG Meeting (Members ONLY) - continuation
(Concorde Ballroom)

SME Compliance Workshop - continuation
(Aiglon Room)

16.00 - 17.30Joint ECC-DDCG Meeting
(Concorde Ballroom)
18.00 - 19.30Welcome Reception & PwC Compliance Achievement Award Sponsored by PwC - confirmed
(Imperial Room)

3 May

09.00 - 09.30

Opening Panel
(Concorde Ballroom)

Moderator: Ingmar de Gooijer (invited)

Speakers:

  • Roeland Van Aelst, VP Healthcare Compliance EMEA & Canada, Johnson & Johnson and chairman of the MTE Ethics & Compliance Committee (confirmed)
  • Bronwen Taylor, Vice President, Compliance & Risk Management, Stryker and chairwoman of the AdvaMed DDCG (confirmed)

Description: The two associations’ Compliance Chairpersons will discuss MedTech Europe & AdvaMed priorities, including the key priority of Code compliance and how this topic underpins all other themes addressed by the industry. Issues such as Code convergence will also be addressed.

09.30 - 10.00

Keynote Speech - Considerations for industry
(Concorde Ballroom)

  • Charles Duchaine, Director,  French Anti-corruption Agency (AFA) (invited)
10.00 - 10.45

CEO Panel
(Concorde Ballroom)

Speaker:

  • Michelle Brennan, Company Group Chair, Medical Devices EMEA, Johnson & Johnson and Chairwoman of the MedTech Europe's Board of Directors (confirmed)
  • David Perez, President & CEO, Terumo BCT, Chairman, Blood Management Business (confirmed)

Moderator: Ingmar de Gooijer

Description: A diverse panel of MedTech senior executives share thoughts on ethics and compliance; explain how they voice the compliance "tone at the top;" comment on the value and role of compliance within a MedTech company and comment on the role of trade associations in ethics and compliance. This panel will also examine CEOs’ perspectives on current trends in compliance (e.g. relationships with patient organisations, transparency, value-based healthcare and direct sponsorship phase-out).

10.45 - 11.15Networking break
(Imperial-Aiglon Room)
11.15 - 12.30

Plenary 1 - “HealthTech – what does it mean for compliance?”
(Concorde Ballroom)

Speakers:

  • Ted Acosta, Vice Chair, Risk Management, EY (confirmed)
  • Rachel Haverfield, Senior Director & Legal Counsel EMEA, Illumina (invited) 

Moderator: Ingmar de Gooijer

Description: HealthTech could be defined as the use of technology (e.g. databases, applications, services, mobiles, wearables) to improve the delivery, payment, and/or consumption of care, with the ability to increase the development and commercialization of more traditional MedTech products. For companies, the implications are profound, and these new commercial models present opportunities but also significant challenges and there is also an ever growing set of regulatory guidelines, which are often outdated before they enter into force. Where do these companies stand on the issue of compliance? What can MedTech learn from them? What can we learn from each other? The discussion is much broader than only privacy as these are new business models, with new risks such as corruption/inducement; direct interactions with patients; competition law and tax aspects.
12.30 - 13.30

Networking lunch 
(Imperial-Aiglon Room)

13.30 - 15.00

Parallel Session 1: Legal & Compliance Risks of Public-Private Partnerships
(Napolean Room)

Moderator

Speakers:

  • Els Janssens, Associate, Baker & McKenzie (confirmed)
  • Enno Behrendt, Legal and Compliance, Siemens Healthcare GmbH (confirmed)

Description: Governments all over the world, but in particular in high growth markets, encounter budget restrictions, but at the same time, they want to compete to further improve quality of care, access to innovation and expertise. One model that these governments are therefore looking at are Healthcare Public Private Partnerships (PPP), but the number of actual projects is still limited and so are the lessons learned. Banking on existing expertise, the panel will discuss the legal and compliance risks of such PPPs.

Parallel Session 2: Distributor compliance: can have, wanna have, must have?
(Vendome Room)

Moderator:

Speakers

  • Kevin Espinoza, Vice President, Global Compliance Officer, BTG (invited)
  • Scott Lane, Executive Chairman, The Red Flag Group (confirmed)

Description: This panel aims at discussing the regulatory changes in their broadest sense and what this means from distributors and their relationship with MedTech companies, considering the different types of relationships that exist. In addition, the Panel will review how to meet mutual expectations, through innovative means (e.g. “Compliance in the Box programs”). 

Parallel Session 3: Leveraging Governmental Affairs strategies to drive compliance objectives
(Tuileries Room)

Speaker: Simon Levitt, Founder and Partner, Harwood Levitt Consulting (invited)

Description: This session is designed as a brainstorming session in order to discuss how the industry can be more effective in shaping national legislation to avoid legislation which is not fit for purpose from a compliance perspective (e.g. transparency laws). Aspects such collaboration between Public Affairs and Compliance teams shall be addressed as well.

15.00 - 15.30

Networking Break
(Imperial-Aiglon Room)

15.30 - 17.15

Ask the Experts session
(Concorde Ballroom)

Main Moderator: Michael Koon, Partner, Norton Rose Fulbright (confirmed)

Description: This session will be set up in roundtable discussions. The time allocated will allow them to get to the heart of key issues. Attendance is limited to 12 persons per table. After 40 minutes, the participants are invited to switch tables. Each table lead will prepare in advance a one-pager with key topics/trends that they plan to address. After the discussions, key discussion points/outcome will be added to this one-pager and circulated to all participants.

Topics & Table Leads:

  • Applying the MedTech Europe Code in France: Olivier Sudre (J&J) (confirmed)
  • MedTech Europe Transparency: Pablo Abad, Legal & Compliance Manager, MedTech Europe (confirmed)
  • Middle East: Ghadeer Al Yacoub, JnJ & Mecomed (confirmed) & Arwa Asiri, Ethical MedTech (confirmed)
  • Turkey: Ceren Aral Desnos, Interim Legal & Compliance Director, MedTech Europe (confirmed)
  • Third Party SMI / Distributors: Scott Lane, Executive Chairman, The Red Flag Group (confirmed)
  • China
  • GDPR / Privacy
18.00 - 19.30

Welcome Cocktail with US Ambassador Jamie McCourt

Venue: Hôtel de Talleyrand – George Marshall Center (Paris)

Sponsor: Ernst and Young (confirmed)

20.00 - 22.30

GMTCC Networking Dinner

Venue: Restaurant La Gare

Sponsor: Red Flag (confirmed)

4 May

8.00 - 9.00Registration & Welcome Coffee
(Imperial-Aiglon Room)
8.00 - 9.00Breakfast meeting for Healthcare Organisations & Professionals Conference Organisers (confirmed)
09.00 - 10.15

Plenary 2: What is the value of compliance?
(Concorde Ballroom)

Speakers:

  • Erinn Hutchinson, Principal, PwC (confirmed)
  • Erin Walsh, Assistant Secretary of Commerce for Global Markets & Director General of the U.S. and Foreign Commercial Service (invited)
  • David Perez, President and CEO Terumo BCT (invited)

Moderator: Ingmar de Gooijer

Description: This panel will examine the role of compliance officer through the perspective of different Compliance Officers of organisations such as MedTech/pharma company; Distributor; Hospital. The speakers will also share their perspectives on their key challenges and discuss the common elements as well as differences of their respective jobs.

10.15 - 10.45Networking break
(Imperial-Aiglon Room)
10.45 - 12.30

Parallel Session 1: Exchange of best practices on Educational Grants around the world
(Napoleon Room)

Speakers:

  • Elke Louwette, Congress & Event, WL Gore (confirmed)
  • Felipe Kietzmann, ABIMED and Alcon (invited)

Moderator:

Description: With the phase out of Direct Sponsorship across which came into force in many jurisdictions across the world at the beginning of the year, companies are learning how to structure their educational strategies as well as processes around Educational Grants. This panel will provide insights as to what has worked and not works for different players in different jurisdictions around the world.

Parallel Session 2: Value-based healthcare: what are the legal and compliance issues?
(Vendome Room)

Speakers:

Moderator:

Description: As a follow up of the last conference, where the profound transformational shift as the concept of value was discussed, this panel will discuss the legal and compliance opportunities and challenges these new commercial models present and how organisations such as MedTech Europe and AdvaMed can help to support their members.

Parallel Session 3: Are the seven FCPA elements enough?
(Tuileries Room)

Speakers: Peter Ellingworth, ABHI (confirmed) 

Moderator:

Description: Recent European legislators seem to have gone a step further than the DOJ in regulating what they expect a good compliance program to be. This panel will start with mapping some of the recent legislations and then discuss how to ensure that the company complies with all these requirements.

12.30 - 13.45

Networking Lunch
(Imperial-Aiglon Room)

13.45 - 15.00

Plenary session 3: Consumerisation of Healthcare
(Concorde Ballroom)

Moderator: Ingmar de Gooijer

Speakers:

Description: How do patients organisations and healthcare watchdogs consider and judge ethics and compliance efforts of the industry? What is their advice on what are the key issues, potential conflicts of interests and how to best address these? What is their stand on transparency (e.g. who is responsible for transparency? How far should transparency go?)

15.00 - 15.15

Plenary session: Closing remarks & discussions
(Concorde Ballroom)

Moderator: Ingmar de Gooijer

Speakers:

  • Roeland Van Aelst, VP Healthcare Compliance EMEA & Canada, Johnson & Johnson and chairman of the MTE Ethics & Compliance Committee (invited)
  • Bronwen Taylor, Vice President, Compliance & Risk Management, Stryker and chairwoman of the AdvaMed DDCG (confirmed)